Table 1:

Pharmacological compounds used throughout the article.

Compound name	Protein target	Concentration	Supplier	Catalog number
Nerve growth factor	TrkA	100 ng/µl	BD Biosciences	356004
740YPDGFR	PI3K activator	50 µg/ml	Tocris Bioscience	1983
LY294002	PI3K inhibitor	10 µM	Tocris Bioscience	1130
Wortmannin	PI3K inhibitor	10 µM	Enzo Life Sciences	BML-ST415
PI-103	PI3K C1 α inhibitor	50 nM	Echelon Biosciences	B0303
IC87114	PI3K C1 δ inhibitor	5 µM	Echelon Biosciences	B0305
AS605240	PI3K C1 γ	25 nM	Echelon Biosciences	B0301
Y-27632	ROCK inhibitor	5 μM	Cayman Chemical	10005583
Akt1/2 kinase IH	Akt 1/2 inhibitor	500 nM	Sigma-Aldrich	A6730-5MG
U0126	MEK inhibitor	10 μM	Cayman Chemical	70970
U73122	PLC inhibitor	10 μM	Enzo Life Sciences	BML-ST391
Chelerythrine	PKC inhibitor	10 μM	Sigma-Aldrich	0C020953 2-1 MG
PP2	cSrc inhibitor	500 nM	EMD Millipore	529573-1 MG
DADLE	δR-agonist	10 μM	Tocris	3790